---
title: "Astrazeneca: In the DESTINY - Breast05 Phase III trial, compared to trastuzumab emtansine, Enhertu r"
description: "Astrazeneca: In the DESTINY - Breast05 Phase III trial, compared to trastuzumab emtansine, Enhertu reduced the risk of disease recurrence or death by 53% in high-risk HER2-positive early breast cancer"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261731605.md"
published_at: "2025-10-18T14:39:23.000Z"
---

# Astrazeneca: In the DESTINY - Breast05 Phase III trial, compared to trastuzumab emtansine, Enhertu r

> Astrazeneca: In the DESTINY - Breast05 Phase III trial, compared to trastuzumab emtansine, Enhertu reduced the risk of disease recurrence or death by 53% in high-risk HER2-positive early breast cancer patients receiving neoadjuvant therapy

Astrazeneca: In the DESTINY - Breast05 Phase III trial, compared to emtansine, Enhertu reduced the risk of disease recurrence or death by 53% in high-risk HER2-positive early breast cancer patients receiving neoadjuvant therapy

### Related Stocks

- [AZN.US - AstraZeneca](https://longbridge.com/en/quote/AZN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| AstraZeneca Says US FDA Approves Calquence Combo for Certain Blood Cancer Patients | AstraZeneca Says US FDA Approves Calquence Combo for Certain Blood Cancer Patients | [Link](https://longbridge.com/en/news/276444179.md) |
| AstraZeneca PLC $AZN Shares Sold by Ontario Teachers Pension Plan Board | Ontario Teachers Pension Plan Board reduced its stake in AstraZeneca PLC (NASDAQ:AZN) by 41% in Q3, now holding 817,880  | [Link](https://longbridge.com/en/news/276339476.md) |
| Maine CDC reports 4 additional cases of measles have been confirmed in Maine | Maine CDC reports 4 additional cases of measles have been confirmed in Maine | [Link](https://longbridge.com/en/news/276164223.md) |
| Daiichi Sankyo and AstraZeneca get EU validation for Enhertu use | Daiichi Sankyo and AstraZeneca have received validation from the European Medicines Agency for their application to exte | [Link](https://longbridge.com/en/news/276408087.md) |
| 08:46 ETCenter for Asbestos Related Disease, Inc. (CARD) Invites Community Members to Attend an Open House and Ribbon Cutting Celebration | The Center for Asbestos Related Disease, Inc. (CARD) is hosting an Open House and Ribbon Cutting celebration on February | [Link](https://longbridge.com/en/news/276235741.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.